Ravelcare
Close ·
Key Fundamentals
SMEPersonal ProductsFMCGPrice-based figures at the close · TTM
- ROCE
- 30.50%
- Debt to Equity
- 0.00
- EPS (TTM)
- —
- Book Value
- ₹54.54
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 1.61
- ROE
- 22.20%
- Dividend Yield
- 0.00%
- EBITDA
- ₹7.10 Cr
- 52W High
- ₹215.00
- 52W Low
- ₹80.80
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 81/100
Category scores
- Quality
- 28
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 29
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 49
- Average
- Sales & profit trajectory 9% weight
- Financial Health
- 88
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 4
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 31
- Poor
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is almost debt free.
- Company has delivered good profit growth of 119% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 44.8%
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 45.1 to 96.3 days.
- Working capital days have increased from 45.6 days to 119 days
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 11 | 7 | 1 |
| Oscillators | Neutral | 1 | 7 | 1 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 40.59
- Neutral
- MACD (12,26,9)
- −3.89
- Bullish
- SMA (50)
- 102.10
- Bearish
- SMA (200)
- 140.01
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | — |
|---|---|
| 3Y | +97.85% |
| 1Y | +7.89% |
5Y: The statements do not go back far enough for this window.
Net profit
| 5Y | Turned to profit |
|---|---|
| 3Y | +109.51% |
| 1Y | +1.18% |
Operating cash flow
| 5Y | — |
|---|---|
| 3Y | Turned negative |
| 1Y | Outflow widened by ₹14.29 Cr |
5Y: The statements do not go back far enough for this window.
Operating margin· change in pp
| 5Y | — |
|---|---|
| 3Y | +11.57 pp |
| 1Y | −1.07 pp |
5Y: The statements do not go back far enough for this window.
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2021 | — |
|---|---|
| Mar 2022 | ₹0.79 Cr |
| Mar 2023 | ₹3.48 Cr |
| Mar 2024 | ₹22.06 Cr |
| Mar 2025 | ₹24.98 Cr |
| Mar 2026 | ₹26.95 Cr |
Net profit by year
| Mar 2021 | −₹0.11 Cr |
|---|---|
| Mar 2022 | −₹0.23 Cr |
| Mar 2023 | ₹0.56 Cr |
| Mar 2024 | ₹5.10 Cr |
| Mar 2025 | ₹5.09 Cr |
| Mar 2026 | ₹5.15 Cr |
Quarterly Results
₹ Cr| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 14.58 | 12.56 |
| Expenses | 13.3 | 9.84 |
| Operating Profit | 1.28 | 2.72 |
| OPM % | 8.78% | 21.66% |
| Other Income | 0.27 | 0.04 |
| Interest | 0 | 0 |
| Depreciation | 0.05 | 0.03 |
| PBT | 1.5 | 2.73 |
| Tax % | 0.67% | 28.57% |
| Net Profit | 1.5 | 1.95 |
| EPS (₹) | 3 | 2.84 |
Profit & Loss
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | — | 0.79 | 3.48 | 22.06 | 24.98 | 26.95 |
| Expenses | — | 1 | 2.97 | 15.35 | 18.16 | 19.88 |
| Operating Profit | — | −0.21 | 0.51 | 6.71 | 6.82 | 7.07 |
| OPM % | — | −26.58% | 14.66% | 30.42% | 27.3% | 26.23% |
| Other Income | — | 0 | 0 | 0.19 | 0.32 | 0.09 |
| Interest | 0 | 0.01 | 0 | 0.07 | 0.01 | 0.02 |
| Depreciation | 0 | 0 | 0 | 0.02 | 0.1 | 0.07 |
| PBT | −0.11 | −0.22 | 0.51 | 6.81 | 7.03 | 7.07 |
| Tax % | 0% | 0% | −11.76% | 25.11% | 27.74% | 27.02% |
| Net Profit | −0.11 | −0.23 | 0.56 | 5.1 | 5.09 | 5.15 |
| EPS (₹) | −0.22 | −0.46 | 1.12 | 10.2 | 10.17 | 7.51 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.01 | 0.01 | 5.01 | 6.86 |
| Reserves | −0.12 | −0.35 | 0.16 | 5.25 | 5.34 | 30.55 |
| Borrowings | 0.12 | 0.42 | 0.41 | 0.04 | 0 | 0 |
| Other Liabilities | 0 | −0.01 | 1.17 | 4.18 | 1.28 | 2.92 |
| Total Liabilities | 0.01 | 0.07 | 1.75 | 9.48 | 11.63 | 40.33 |
| Fixed Assets | 0 | 0 | 0.01 | 0.22 | 0.16 | 0.11 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 2.48 |
| Investments | 0 | 0 | 0 | 0.79 | 3.07 | 4.51 |
| Other Assets | 0.01 | 0.07 | 1.74 | 8.47 | 8.4 | 33.23 |
| Total Assets | 0.01 | 0.07 | 1.75 | 9.48 | 11.63 | 40.33 |
Cash Flow
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | — | −0.41 | 1 | 6.49 | −3.18 | −17.47 |
| Investing | — | 0 | −0.01 | −6.92 | 3.81 | −4.12 |
| Financing | — | 0.41 | −0.01 | −0.44 | −0.04 | 21.91 |
| Net Cash Flow | — | 0 | 0.98 | −0.87 | 0.59 | 0.32 |
| Free Cash Flow | — | −0.41 | 0.99 | 6.26 | −3.22 | −19.97 |
| CFO/EBITDA | — | 195 | 196 | 122 | −22 | −231 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | — | 0 | 0 | 2.81 | 36.24 | 96.29 |
| Inventory Days | — | 0 | 307 | 24.18 | 104 | 90.21 |
| Days Payable | — | — | 149 | 72.55 | 21.22 | 71.81 |
| Cash Conversion Cycle | — | 0 | 158 | −45.55 | 119 | 115 |
| Working Capital Days | — | −166 | −87.05 | −31.93 | 49.83 | 119 |
| ROCE % | — | −466.67% | 154.55% | 234.01% | 89.33% | 30.49% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Ravelcare insights
51 extracted metrics across FY21–FY26.
Documents
Frequently Asked Questions about Ravelcare
What does Ravelcare Ltd do?
Where is Ravelcare Ltd (RAVEL) listed?
Which sector does Ravelcare Ltd belong to?
What is the 52-week high and low of Ravelcare Ltd?
What is the Return on Equity (ROE) of Ravelcare Ltd?
Company Information
Incorporated in November 2018, Ravelcare Ltd. is a digital-first beauty and personal care (BPC) brand offering a comprehensive range of products.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544629.md for Ravelcare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.